Sign inJoin waitlistJoin the waitlist

Natraj Ammakkanavar

Physician · Community Health Network

Credentials: · · · ·

History

Community Health Network
Present

Hematology and Medical Oncology
2014–2017
Internal Medicine
Icahn School of Medicine at Mount Sinai
2011–2014
Doctor of Medicine
2003–2007

Research

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206
Annals of Oncology · 2018 · 164 citations
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers
Oncotarget · 2016 · 78 citations
Adjuvant therapy for endometrial cancer
Review · Journal of Gynecologic Oncology · 2014 · 26 citations

Girish Nadkarni
6 papers · 6 as a resident
Narender Annapureddy
6 papers
MS
Manpreet Sabharwal
5 papers · 5 as a resident
SA
Shiv Kumar Agarwal
5 papers · 5 as a resident
VK
Vijay Kanakadandi
5 papers · 4 as a fellow
Hari Priya Sanjani
3 papers · 1 as a resident
PS
Priya Simoes
3 papers · 3 as a resident
Alexandre Malek
2 papers · 2 as a fellow
AB
Arvinder Bhinder
2 papers
Bert O'Neil
2 papers
Bilal Siddiqui
2 papers
Bruno Granwehr
2 papers

Clinical trials

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Site PI · Recruiting · Phase 1, Phase 2
Pathos AI, Inc.
2025–2029
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2023–2031
GEMINI-NSCLC: NSCLC Biomarker Study
Site PI · Recruiting
Tempus AI
2022–2029